Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 1 | $7,750 |
| Sells | 24 | $257,729 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 20 Mar 2025 16:34 | CTMX | CytomX Therapeutics Inc | MCCARTHY SEAN A. | CEO | 18 Mar 2025 | Sale | 37,656 | 0.599 | 22,556 | D |
| 20 Mar 2025 16:33 | CTMX | CytomX Therapeutics Inc | OGDEN CHRISTOPHER | Chief Financial Officer | 18 Mar 2025 | Sale | 8,551 | 0.599 | 5,122 | D |
| 20 Mar 2025 16:32 | CTMX | CytomX Therapeutics Inc | CHU YU-WAYE | Chief Medical Officer | 18 Mar 2025 | Sale | 4,025 | 0.599 | 2,411 | D |
| 20 Mar 2025 16:32 | CTMX | CytomX Therapeutics Inc | ROWLAND LLOYD A | General Counsel | 18 Mar 2025 | Sale | 10,203 | 0.599 | 6,112 | D |
| 20 Mar 2025 16:31 | CTMX | CytomX Therapeutics Inc | BELVIN MARCIA | SVP, Chief Scientific Officer | 18 Mar 2025 | Sale | 19,512 | 0.599 | 11,688 | D |
| 22 Aug 2024 18:01 | CTMX | CytomX Therapeutics Inc | LANDAU JEFFREY B | Chief Business Officer | 20 Aug 2024 | Sale | 4,181 | 1.2291 | 5,139 | D |
| 22 Aug 2024 18:01 | CTMX | CytomX Therapeutics Inc | BELVIN MARCIA | SVP, Chief Scientific Officer | 20 Aug 2024 | Sale | 4,181 | 1.2291 | 5,139 | D |
| 22 Aug 2024 18:00 | CTMX | CytomX Therapeutics Inc | ROWLAND LLOYD A | General Counsel | 20 Aug 2024 | Sale | 4,181 | 1.2291 | 5,139 | D |
| 22 Aug 2024 17:59 | CTMX | CytomX Therapeutics Inc | OGDEN CHRISTOPHER | Chief Financial Officer | 20 Aug 2024 | Sale | 1,984 | 1.2291 | 2,439 | D |
| 22 Aug 2024 17:58 | CTMX | CytomX Therapeutics Inc | MCCARTHY SEAN A. | CEO | 20 Aug 2024 | Sale | 13,898 | 1.2291 | 17,082 | D |
| 21 Mar 2024 16:41 | CTMX | CytomX Therapeutics Inc | ROWLAND LLOYD A | General Counsel | 19 Mar 2024 | Sale | 5,268 | 2.0855 | 10,986 | D |
| 21 Mar 2024 16:40 | CTMX | CytomX Therapeutics Inc | MCCARTHY SEAN A. | CEO | 19 Mar 2024 | Sale | 20,223 | 2.0855 | 42,175 | D |
| 21 Mar 2024 16:38 | CTMX | CytomX Therapeutics Inc | OGDEN CHRISTOPHER | SVP, Finance and Accounting | 19 Mar 2024 | Sale | 2,971 | 2.0855 | 6,196 | D |
| 21 Mar 2024 16:37 | CTMX | CytomX Therapeutics Inc | BELVIN MARCIA | SVP, Chief Scientific Officer | 19 Mar 2024 | Sale | 12,795 | 2.0855 | 26,684 | D |
| 21 Mar 2024 16:36 | CTMX | CytomX Therapeutics Inc | LANDAU JEFFREY B | Chief Business Officer | 19 Mar 2024 | Sale | 6,562 | 2.0855 | 13,685 | D |
| 22 Dec 2023 16:16 | CTMX | CytomX Therapeutics Inc | MCCARTHY SEAN A. | CEO | 20 Dec 2023 | Sale | 13,551 | 1.3807 | 18,710 | D |
| 22 Dec 2023 16:14 | CTMX | CytomX Therapeutics Inc | BELVIN MARCIA | SVP, Chief Scientific Officer | 20 Dec 2023 | Sale | 4,077 | 1.3805 | 5,628 | D |
| 22 Dec 2023 16:12 | CTMX | CytomX Therapeutics Inc | LANDAU JEFFREY B | Chief Business Officer | 20 Dec 2023 | Sale | 4,077 | 1.3805 | 5,628 | D |
| 22 Dec 2023 16:11 | CTMX | CytomX Therapeutics Inc | ROWLAND LLOYD A | General Counsel | 20 Dec 2023 | Sale | 4,077 | 1.3807 | 5,629 | D |
| 22 Dec 2023 16:10 | CTMX | CytomX Therapeutics Inc | OGDEN CHRISTOPHER | SVP, Finance and Accounting | 20 Dec 2023 | Sale | 1,990 | 1.3806 | 2,747 | D |
| 22 Sep 2023 19:16 | CTMX | CytomX Therapeutics Inc | BELVIN MARCIA | SVP, Chief Scientific Officer | 22 Sep 2023 | Sale | 4,119 | 1.3003 | 5,356 | D |
| 22 Sep 2023 19:15 | CTMX | CytomX Therapeutics Inc | LANDAU JEFFREY B | Chief Business Officer | 22 Sep 2023 | Sale | 4,119 | 1.3003 | 5,356 | D |
| 22 Sep 2023 19:13 | CTMX | CytomX Therapeutics Inc | MCCARTHY SEAN A. | CEO | 22 Sep 2023 | Sale | 14,601 | 1.3004 | 18,987 | D |
| 22 Sep 2023 19:12 | CTMX | CytomX Therapeutics Inc | ROWLAND LLOYD A | General Counsel | 22 Sep 2023 | Sale | 5,486 | 1.3006 | 7,135 | D |
| 31 Mar 2023 19:56 | CTMX | CytomX Therapeutics Inc | JONES ELAINE V | Director | 29 Mar 2023 | Purchase | 5,000 | 1.55 | 7,750 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)